4 results
diagnosis treatment antinxp2 antinxp2dm dermatology dermatomyositis differential gastroenterology hcc hepatocellular hepatology hhv8 hivaids idsa infections kaposisarcoma monoclonal opportunistic paraproteinemias prevention
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline First Line Treatment for HCC with Preserved
Hepatocellular Carcinoma ... Treatment for Disease ... Systemic #Treatment #Management ... #Hepatology #Gastroenterology ... #oncology #Pharmacology
Paraproteinemias Entities That Can Feature A Monoclonal Protein/M Component: • MM • WM • MGUS • MGCS • MGRS • Splenic Marginal Zone
• Heavy Chain disease ... Alpha & Mu) Skin ... component+neuropathy+Castleman ... Paraproteinemias #Hematology ... Differential #Diagnosis #Oncology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
, Multicentric Castleman ... ’s Disease (MCD) ... involvement of skin ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Anti-NXP-2 Dermatomyositis What? DM with generalized subcutaneous edema Pts have more myalgias, more severe weakness, and an increased prevalence
have typical DM skin ... dorsal part of the MCP ... ulcerations • Skin ... had more severe disease ... Dermatomyositis #diagnosis #management
No results found for "MCL hematology video management skin oncology pharmacology carcinoma disease castlemans"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #MCL #hematology #video #management #skin #oncology #pharmacology #carcinoma #disease #castlemans